Myopia and presbyopia treatment market to hit $32.74b by 2030

Developments include low-dose atropine eye drops and LASIK procedures.

The global myopia and presbyopia treatment market is projected to reach a value of $32.74b by 2030 at a compound annual growth rate of 8.2%, according to Research and Markets.

The sector’s expansion is attributed to advancements in technology such as low-dose atropine eye drops for slowing myopia progression in children and laser-assisted in situ keratomileusis (LASIK) surgical procedures.

The market is also being driven by demographic shifts, particularly the ageing global population, along with public health initiatives.

“Public health initiatives continue to stress the importance of regular eye examinations, leading to early diagnosis and intervention, thereby contributing to market expansion,” the report said.